Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound nanometer preparation for treating diabetes mellitus type 2 and preparation method thereof

A type 2 diabetes and nano-preparation technology, which is applied in the direction of medical preparations containing active ingredients, metabolic diseases, microcapsules, etc., can solve the problems that insulin cannot be taken orally, and blood sugar cannot be well controlled, so as to improve the immune function of the body , mobilize the body's immunity and delay absorption

Inactive Publication Date: 2016-06-08
李华红
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In general, if you still can't control your blood sugar well by changing your lifestyle and using oral hypoglycemic drugs, or when taking other drugs will have adverse effects on you, your doctor may recommend insulin
Currently, insulin cannot be taken orally and can only be injected subcutaneously using a device such as a syringe or an insulin pen

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound nanometer preparation for treating diabetes mellitus type 2 and preparation method thereof
  • Compound nanometer preparation for treating diabetes mellitus type 2 and preparation method thereof
  • Compound nanometer preparation for treating diabetes mellitus type 2 and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] A compound nano-preparation for treating type 2 diabetes, which mainly consists of the following ingredients in parts by weight: 8 parts of aloe acetylated glucomannan, 3 parts of ciclotanine, 1 part of decanoyl acetaldehyde, and syringaresin monoglycoside 4 parts, 5 parts of banana leaf powder, 3 parts of grapefruit seed extract, 1 part of sodium edetate, 0.8 parts of myristic acid, 0.1 part of syringic acid, 0.1 part of gentisic acid, 3 parts of lysine, Carotene 1 part, antioxidant 0.03 part.

[0025] Wherein, the particle size of the banana leaf powder is 100 μm, and the preparation process of the banana leaf powder is as follows: take fresh banana leaves and wash them, soak them in 0.5% sodium bicarbonate solution for 30 minutes, remove them, dry them in the air, and place Dried in a dryer until the water content is lower than 5%, pulverized into a 40-mesh coarse powder with a pulverizer, and then pulverized into a 100 μm fine powder with a superfine pulverizer to o...

Embodiment 2

[0031] A compound nano-preparation for treating type 2 diabetes, which mainly consists of the following ingredients in parts by weight: 11.5 parts of aloe acetylated glucomannan, 4.5 parts of cclotanine, 1.5 parts of decanoyl acetaldehyde, syringaresin monoglycoside 6 parts, 12.5 parts of banana leaf powder, 5 parts of grapefruit seed extract, 2.5 parts of sodium edetate, 1.4 parts of myristic acid, 0.3 parts of syringic acid, 0.2 parts of gentisic acid, 6.5 parts of lysine, Carotene 2 parts, antioxidant 0.065 parts.

[0032] Wherein, the particle size of the banana leaf powder is 300 μm, and the preparation process of the banana leaf powder is as follows: take fresh banana leaves and wash them, soak them in 0.85 sodium bicarbonate solution for 45 minutes, remove them, dry them in the air, place Dried in a dryer until the water content is lower than 5%, pulverized into a 40-mesh coarse powder with a pulverizer, and then pulverized into a 300 μm fine powder with a superfine pulve...

Embodiment 3

[0038] A compound nano-preparation for treating type 2 diabetes, which mainly consists of the following ingredients in parts by weight: 15 parts of aloe acetylated glucomannan, 6 parts of ciclotanine, 2 parts of decanoyl acetaldehyde, syringaresin monoglycoside 8 parts, 20 parts of banana leaf powder, 7 parts of grapefruit seed extract, 4 parts of sodium edetate, 2.0 parts of myristic acid, 0.5 parts of syringic acid, 0.3 parts of gentisic acid, 10 parts of lysine, 3 parts of carotenoid, 0.1 part of antioxidant.

[0039] Wherein, the particle size of the banana leaf powder is 500 μm, and the preparation process of the banana leaf powder is as follows: take fresh banana leaves and wash them, soak them in 1.2% sodium bicarbonate solution for 60 minutes, remove them, dry them in the air, and place Dried in a dryer until the water content is lower than 5%, pulverized into a 40-mesh coarse powder with a pulverizer, and then pulverized into a 500 μm fine powder with a superfine pulv...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
particle diameteraaaaaaaaaa
particle diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses a compound nanometer preparation for treating the diabetes mellitus type 2 and a preparation method thereof. The compound nanometer preparation for treating the diabetes mellitus type 2 is mainly prepared from, by weight, 8-15 parts of aloe acetylation gulcomannan, 3-6 parts of Cicletanine, 1-2 parts of decanoyl acetaldehyde, 4-8 parts of syringaresinol monoglucoside, 5-20 parts of banana leaf powder, 3-7 parts of grapefruit seed extract, 1-4 parts of sodium ethylene diamine tetracetate, 0.8-2.0 parts of myristic acid, 0.1-0.5 part of syringic acid, 0.1-0.3 part of gentisic acid, 3-10 parts of lysine, 1-3 parts of carotenoid and 0.03-0.1 part of antioxidant. According to the compound nanometer preparation, blood glucose rising is controlled through interaction of various ingredients, the blood pressure and blood fat of a patient suffering from the diabetes mellitus type 2 are adjusted, sufficient nutritional ingredients can be provided for the patient suffering from the diabetes mellitus type 2, the immunity of the patient is improved, diabetes mellitus and arteriosclerosis are relieved, the effect of treating the diabetes mellitus type 2 is remarkable, and the side effect is small.

Description

technical field [0001] The invention relates to the field of medicines related to diabetes, in particular to a compound nano-preparation for treating type 2 diabetes and a preparation method thereof. Background technique [0002] Diabetes is a disease process caused by multiple etiologies, affecting 6%-7% of the world's population, and the number of patients is expected to double to 300 million by 2025. The cardinal feature of diabetes is hyperglycemia, which is caused by defective insulin secretion or its biological action, or both. The long-term high blood sugar in diabetes leads to chronic damage and dysfunction of various tissues, especially the eyes, kidneys, heart, blood vessels, and nerves. [0003] Type 2 diabetes is common in middle-aged and elderly people, and obese people have a high incidence rate, often accompanied by hypertension, dyslipidemia, arteriosclerosis and other diseases. The onset is insidious, without any symptoms in the early stage, or only mild f...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/06A61K36/88A61K9/50A61P3/10A61K31/736A61K31/7048A61K31/4355A61K31/20A61K31/198A61K31/192A61K31/185A61K31/015
CPCA61K9/501A61K9/5036A61K9/5052A61K9/5073A61K31/015A61K31/185A61K31/192A61K31/198A61K31/20A61K31/4355A61K31/7048A61K31/736A61K36/752A61K36/88A61K38/06A61K2300/00
Inventor 李华红韩晓丽
Owner 李华红
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com